The new era of cellulite treatment
DESIGNED to RECREATE
In the evolutionary phases (I-IV) of cellulite, clinically called “Edematous Fibrosclerotic Panniculopathy” (EFP) the intradermal therapy was mainly addressed to the treatment of edema and microcirculation.
Today, numerous pathophysiological considerations demonstrate the need to intervene also and especially on the Extra Cellular Matrix (ECM).
The synergy of the mix of HA, AA and an Alkaline Solution[1]:
Sunekos Cell acts:
- Promotes the optimization of the ECM protein turnover: neo-collagenesis and not collagenase. (HA + AA)
- Improves the micro-circulation
- Re-equilibrium of the ECM inflammation reducing fibrosis
- Helps to regulate the physiological pH
This new approach is designed to restore the homeostasis of the skin and adipose tissue thanks to a non-lipoclastic or lipolytic method.
REBUILDING
rather than
DESTROYING
STAGES OF CELLULITE
BEFORE AND AFTER
Courtesy by Elena Fasola MD
Courtesy by Elena Fasola MD
Courtesy by Elena Fasola MD
Courtesy by Mark Holmes MD
CLINICAL EVALUTATION
Preliminary study on 25 healthy subjects with different stages of cellulite, divided into 2 groups, undergoing Sunekos Cell treatment.[3]
Group A: 11 subjects with stages I and II cellulite
Group B: 14 subjects with stages III and IV cellulite
Clinical, morphometric and ultrasound evaluation at baseline, 1 month and 4 months after the treatment
CONCLUSIONS
- Effectiveness of Sunekos Cell.
CIRCUMFERENCES (thigh)
VISUAL ASPECT GRADE
ULTRASOUND
RESULTS*
- Clinical evaluation score is reduced in both groups also thanks to the injective technique adapted to the severity of the disease.
- Maintenance of results after 4 months.
BIBLIOGRAPHY
[1] Fasola E. Cellulite rebuild rather than destroy – Prime Vol 13 Issue 1 2023
[2] Lemperle G. et al. The Direction of optimal skin incisions Derived from Striae Distensae – Plast. Reconstr. Surg. 2014 Dec;134(6):1424-1434.
[3] A. Sparavigna, Injective treatment of the so-called cellulite: a new approach aimed at restructuring extracellular matrix of deeper layers of the skin. Efficacy and safety of a new specific formula (part 1 & 2) – JPD Vol 18 n2 2022